Alx Oncology Holdings Inc. · NASDAQ:ALXO
venBio Global Strategic Fund, L.P. reported a 3.30% stake in Alx Oncology Holdings Inc. (Schedule 13D/A)
Event Oct 14, 2026 · Filed Oct 16, 2026
venBio Global Strategic Fund, L.P. reported a 3.30% stake in Alx Oncology Holdings Inc., 4,307,034 shares, with active intent on Oct 14, 2026. Filed Oct 16, 2026 (Schedule 13D/A).
- Stake
- 3.30%
- Shares
- 4,307,034
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| venBio Global Strategic Fund, L.P. | 3.30% | 4,307,034 |
| venBio Global Strategic Fund II L.P. | 6.50% | 8,453,038 |
| venBio Global Strategic GP, L.P. | 3.30% | 4,307,034 |
| venBio Global Strategic GP II, L.P. | 6.50% | 8,453,038 |
| venBio Global Strategic GP, Ltd. | 3.30% | 4,307,034 |
| venBio Global Strategic GP II, Ltd. | 6.50% | 8,453,038 |
| GOODMAN COREY S | 9.99% | 12,927,442 |
Source
Download original · View original at SEC
Related
- Alx Oncology Holdings Inc.
- venBio Global Strategic Fund, L.P.
- Alx Oncology Holdings Inc. shareholders
- Form 4 · Lettmann Jason · Aug 18, 2026
- Form 4 · Wong Shelly · Aug 18, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Wong Shelly · Jul 6, 2026